Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 30, 2004 - Issue 1
Submit an article Journal homepage
250
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Powder‐in‐Bottle Formulation of SU011248. Enabling Rapid Progression into Human Clinical Trials

Anand Sistla Sugen Inc. (a Pharmacia Company), 230 E. Grand Ave, S., San Francisco, California, 94080, USA; Pfizer Inc., 10646 Science Center Drive, San Diego, California, 92121, USA
,
Alan Sunga Sugen Inc. (a Pharmacia Company), 230 E. Grand Ave, S., San Francisco, California, 94080, USA
,
Kenneth Phung Sugen Inc. (a Pharmacia Company), 230 E. Grand Ave, S., San Francisco, California, 94080, USA
,
Arun Koparkar Sugen Inc. (a Pharmacia Company), 230 E. Grand Ave, S., San Francisco, California, 94080, USA
&
Narmada Shenoy Sugen Inc. (a Pharmacia Company), 230 E. Grand Ave, S., San Francisco, California, 94080, USA
Pages 19-25 | Published online: 02 Feb 2004

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Keren Paz & Zhenping Zhu. (2005) Recent advances in targeted therapy of human myelogenous leukaemia. Expert Opinion on Therapeutic Targets 9:6, pages 1147-1163.
Read now

Articles from other publishers (12)

Emma C. Bernsen, Valery J. Hogenes, Bastiaan Nuijen, Lidwien M. Hanff, Alwin D. R. Huitema & Meta H. M. Diekstra. (2022) Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 14:12, pages 2834.
Crossref
Lorenzo Capretto, Gerard Byrne, Sarah Trenfield, Lee Dowden & Steven Booth. 2017. Oral Formulation Roadmap from Early Drug Discovery to Development. Oral Formulation Roadmap from Early Drug Discovery to Development 165 241 .
Lanfang Bai, Joy C. Yang, Joon‐ha Ok, Philip C. Mack, Hsing‐Jien Kung & Christopher P. Evans. (2011) Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration. International Journal of Cancer 130:11, pages 2693-2702.
Crossref
Steven G. DuBois, Suzanne Shusterman, Joel M. Reid, Ashish M. Ingle, Charlotte H. Ahern, Sylvain Baruchel, Julia Glade-Bender, Percy Ivy, Peter C. Adamson & Susan M. Blaney. (2011) Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study. Cancer Chemotherapy and Pharmacology 69:4, pages 1021-1027.
Crossref
Masha S. H. Lam. (2012) Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:2, pages 164-192.
Crossref
Fariba Navid, Robbin Christensen, Patton Minkin, Clinton F Stewart, Wayne L Furman & Sharyn Baker. (2008) Stability of Sunitinib in Oral Suspension. Annals of Pharmacotherapy 42:7-8, pages 962-966.
Crossref
Keren Paz & Zhenping Zhu. 2007. Cancer. Cancer 333 382 .
Daniel Mufson, Madhu Pudipeddi & Abu Serajuddin. 2006. The Process of New Drug Discovery and Development, Second Edition. The Process of New Drug Discovery and Development, Second Edition 15 51 .
Dick Johan van Spronsen & Pieter H.M. De Mulder. (2006) Targeted Approaches for Treating Advanced Clear Cell Renal Carcinoma. Oncology Research and Treatment 29:8-9, pages 394-402.
Crossref
R. Kath, A. Schlichter, K. Höffken, A. Heidenreich & P. H. M. De Mulder. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie 4920 4976 .
D.J. van Spronsen, P.F.A. Mulders & P.H.M. De Mulder. (2005) Novel treatments for metastatic renal cell carcinoma. Critical Reviews in Oncology/Hematology 55:3, pages 177-191.
Crossref
D. J. van Spronsen, K. J. M. de Weijer, P. F. A. Mulders & P. H. M. De Mulder. (2005) Novel treatment strategies in clear-cell metastatic renal cell carcinoma. Anti-Cancer Drugs 16:7, pages 709-717.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.